Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee

Roy D Altman

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Osteoarthritis is among the leading causes of pain and reduced function in the USA, and its prevalence is increasing as the 'baby boom generation ages. Present-day therapy is directed at the relief of pain, but the treatment armamentarium for moderate-to-severe osteoarthritis has been incomplete. Most existing treatments do not provide long-lasting effective pain relief and most also carry the risk of potentially distressing and/or dangerous systemic adverse effects. Intra-articular hyaluronan injections have significantly reduced pain for a majority of patients with osteoarthritis of the knee. Although the exact mechanism of action is not known, this treatment replaces lost endogenous hyaluronan and has direct actions on nerve endings, synovial cells and chondrocytes. This article discusses the rationale behind the development of intra-articular hyaluronan injections and describes one formulation that was the first highly purified result of a well-established extraction technique and a non-animal-derived exogenous origin.

Original languageEnglish (US)
Pages (from-to)21-27
Number of pages7
JournalExpert Review of Clinical Immunology
Volume6
Issue number1
DOIs
StatePublished - 2010
Externally publishedYes

Fingerprint

Knee Osteoarthritis
Hyaluronic Acid
Pain
Intra-Articular Injections
Osteoarthritis
Nerve Endings
Population Growth
Therapeutics
Chondrocytes

Keywords

  • Euflexxa
  • Hyaluronan
  • Knee pain
  • Osteoarthritis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee. / Altman, Roy D.

In: Expert Review of Clinical Immunology, Vol. 6, No. 1, 2010, p. 21-27.

Research output: Contribution to journalArticle

@article{0c74be012333476cbef86cbd65811005,
title = "Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee",
abstract = "Osteoarthritis is among the leading causes of pain and reduced function in the USA, and its prevalence is increasing as the 'baby boom generation ages. Present-day therapy is directed at the relief of pain, but the treatment armamentarium for moderate-to-severe osteoarthritis has been incomplete. Most existing treatments do not provide long-lasting effective pain relief and most also carry the risk of potentially distressing and/or dangerous systemic adverse effects. Intra-articular hyaluronan injections have significantly reduced pain for a majority of patients with osteoarthritis of the knee. Although the exact mechanism of action is not known, this treatment replaces lost endogenous hyaluronan and has direct actions on nerve endings, synovial cells and chondrocytes. This article discusses the rationale behind the development of intra-articular hyaluronan injections and describes one formulation that was the first highly purified result of a well-established extraction technique and a non-animal-derived exogenous origin.",
keywords = "Euflexxa, Hyaluronan, Knee pain, Osteoarthritis",
author = "Altman, {Roy D}",
year = "2010",
doi = "10.1586/eci.09.78",
language = "English (US)",
volume = "6",
pages = "21--27",
journal = "Expert Review of Clinical Immunology",
issn = "1744-666X",
publisher = "Expert Reviews Ltd.",
number = "1",

}

TY - JOUR

T1 - Non-avian-derived hyaluronan for the treatment of osteoarthritis of the knee

AU - Altman, Roy D

PY - 2010

Y1 - 2010

N2 - Osteoarthritis is among the leading causes of pain and reduced function in the USA, and its prevalence is increasing as the 'baby boom generation ages. Present-day therapy is directed at the relief of pain, but the treatment armamentarium for moderate-to-severe osteoarthritis has been incomplete. Most existing treatments do not provide long-lasting effective pain relief and most also carry the risk of potentially distressing and/or dangerous systemic adverse effects. Intra-articular hyaluronan injections have significantly reduced pain for a majority of patients with osteoarthritis of the knee. Although the exact mechanism of action is not known, this treatment replaces lost endogenous hyaluronan and has direct actions on nerve endings, synovial cells and chondrocytes. This article discusses the rationale behind the development of intra-articular hyaluronan injections and describes one formulation that was the first highly purified result of a well-established extraction technique and a non-animal-derived exogenous origin.

AB - Osteoarthritis is among the leading causes of pain and reduced function in the USA, and its prevalence is increasing as the 'baby boom generation ages. Present-day therapy is directed at the relief of pain, but the treatment armamentarium for moderate-to-severe osteoarthritis has been incomplete. Most existing treatments do not provide long-lasting effective pain relief and most also carry the risk of potentially distressing and/or dangerous systemic adverse effects. Intra-articular hyaluronan injections have significantly reduced pain for a majority of patients with osteoarthritis of the knee. Although the exact mechanism of action is not known, this treatment replaces lost endogenous hyaluronan and has direct actions on nerve endings, synovial cells and chondrocytes. This article discusses the rationale behind the development of intra-articular hyaluronan injections and describes one formulation that was the first highly purified result of a well-established extraction technique and a non-animal-derived exogenous origin.

KW - Euflexxa

KW - Hyaluronan

KW - Knee pain

KW - Osteoarthritis

UR - http://www.scopus.com/inward/record.url?scp=77649127706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77649127706&partnerID=8YFLogxK

U2 - 10.1586/eci.09.78

DO - 10.1586/eci.09.78

M3 - Article

C2 - 20383887

AN - SCOPUS:77649127706

VL - 6

SP - 21

EP - 27

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

SN - 1744-666X

IS - 1

ER -